Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality
worldwide. Effective prevention and management strategies are essential to reduce the …

Despite significant advances in cancer therapeutics, chemotherapy remains the cornerstone
of treatment for many tumors. Importantly, however, chemotherapy-induced toxicity …

Abstract Background and Aims The detection of cancer therapy-related cardiac dysfunction
(CTRCD) by reduction of left ventricular ejection fraction (LVEF) during chemotherapy …

Background Specific cancer treatments can lead to cancer therapy–related cardiac
dysfunction (CTRCD). Sodium glucose cotransporter-2 inhibitors (SGLT2is) can potentially …

Background Millions of cancer survivors are at risk of cardiovascular diseases, a leading
cause of morbidity and mortality. Tools to potentially facilitate implementation of cardiology …

Data about heart failure in Latin America is scarce. Women living in this region of the world
are exposed to a mix of traditional risk factors for heart failure, neglected diseases, and …

Background Cardiotoxicity is one of the most common adverse events of the chemotherapy.
Physical exercise was shown to be cardioprotective. We aim to estimate the efficacy and …

Background Anthracycline-based chemotherapy represents a cornerstone treatment for a
number of common cancers, including breast cancer, lymphoma, and sarcoma. However …

Breast cancer (BC) is one of the most prevalent cancers worldwide. Fortunately, BC
treatment has taken a huge turn in the last few years. Despite these advances, one of the …

Simple Summary The incidence of cardiac morbimortality in acute myeloid leukemia (AML)
is not well known. We aim to estimate the cumulative incidence (CI) of cardiac events in AML …